Coordinate loss of fragile gene expression in pancreatobiliary cancers: Correlations among markers and clinical features

Mark Bloomston, Jeffrey Kneile, Matthew Butterfield, Mary Dillhoff, Peter Muscarella, E. Christopher Ellison, W. Scott Melvin, Carlo M. Croce, Flavia Pichiorri, Kay Huebner, Wendy L. Frankel

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Loss of expression of fragile gene products, Fhit and Wwox, occurs in many cancer types, with loss exhibited early in the neoplastic process in some. Wwox has been understudied in pancreatobiliary cancers, especially in relation to other involved tumor suppressors. We have assessed the status of the Fhit and Wwox proteins encoded by DNA damage susceptible chromosome fragile sites encompassed by FHIT and WWOX tumor suppressor genes. Methods: Pancreatic, gallbladder and ampullary cancers, normal pancreas, chronic pancreatitis, and benign gallbladder specimens were stained for expression of Fhit, Fhit effector protein Fdxr, Wwox, and other tumor suppressors by immunohistochemistry, and comparisons were made between benign and malignant tissue. Correlations of expression among proteins and clinicopathologic features were sought using Spearman's rank order. Survival curves were created using the Kaplan-Meier method and compared by log-rank analysis. Predictors of survival were determined using multivariate Cox proportional hazards analysis. Results: Fhit and Wwox were ubiquitously expressed in benign samples and significantly and coordinately reduced in pancreatic, gallbladder, and ampullary cancers. In pancreatic cancers, Fdxr expression was positively correlated with Fhit and Wwox expression. Neither Fhit nor Wwox expression correlated with expression of other tumor suppressors or with clinicopathologic characteristics measured. Conclusion: Loss of Fhit and Wwox expression does not predict tumor progression or patient survival, suggesting that loss of expression of genes at the exquisitely replication stress sensitive chromosome fragile regions is an early event in the pathogenesis of cancers of the gallbladder, pancreas, and ampulla.

Original languageEnglish (US)
Pages (from-to)2331-2338
Number of pages8
JournalAnnals of Surgical Oncology
Volume16
Issue number8
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Biomarkers
Gallbladder Neoplasms
Gene Expression
Pancreatic Neoplasms
Neoplasms
Survival
Chromosome Fragile Sites
Neoplastic Processes
Proteins
Chronic Pancreatitis
Gallbladder
Tumor Suppressor Genes
DNA Damage
Chromosomes
Immunohistochemistry

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Coordinate loss of fragile gene expression in pancreatobiliary cancers : Correlations among markers and clinical features. / Bloomston, Mark; Kneile, Jeffrey; Butterfield, Matthew; Dillhoff, Mary; Muscarella, Peter; Ellison, E. Christopher; Melvin, W. Scott; Croce, Carlo M.; Pichiorri, Flavia; Huebner, Kay; Frankel, Wendy L.

In: Annals of Surgical Oncology, Vol. 16, No. 8, 08.2009, p. 2331-2338.

Research output: Contribution to journalArticle

Bloomston, M, Kneile, J, Butterfield, M, Dillhoff, M, Muscarella, P, Ellison, EC, Melvin, WS, Croce, CM, Pichiorri, F, Huebner, K & Frankel, WL 2009, 'Coordinate loss of fragile gene expression in pancreatobiliary cancers: Correlations among markers and clinical features', Annals of Surgical Oncology, vol. 16, no. 8, pp. 2331-2338. https://doi.org/10.1245/s10434-009-0507-4
Bloomston, Mark ; Kneile, Jeffrey ; Butterfield, Matthew ; Dillhoff, Mary ; Muscarella, Peter ; Ellison, E. Christopher ; Melvin, W. Scott ; Croce, Carlo M. ; Pichiorri, Flavia ; Huebner, Kay ; Frankel, Wendy L. / Coordinate loss of fragile gene expression in pancreatobiliary cancers : Correlations among markers and clinical features. In: Annals of Surgical Oncology. 2009 ; Vol. 16, No. 8. pp. 2331-2338.
@article{089f67a9920c4479bb21e07064aafb2d,
title = "Coordinate loss of fragile gene expression in pancreatobiliary cancers: Correlations among markers and clinical features",
abstract = "Background: Loss of expression of fragile gene products, Fhit and Wwox, occurs in many cancer types, with loss exhibited early in the neoplastic process in some. Wwox has been understudied in pancreatobiliary cancers, especially in relation to other involved tumor suppressors. We have assessed the status of the Fhit and Wwox proteins encoded by DNA damage susceptible chromosome fragile sites encompassed by FHIT and WWOX tumor suppressor genes. Methods: Pancreatic, gallbladder and ampullary cancers, normal pancreas, chronic pancreatitis, and benign gallbladder specimens were stained for expression of Fhit, Fhit effector protein Fdxr, Wwox, and other tumor suppressors by immunohistochemistry, and comparisons were made between benign and malignant tissue. Correlations of expression among proteins and clinicopathologic features were sought using Spearman's rank order. Survival curves were created using the Kaplan-Meier method and compared by log-rank analysis. Predictors of survival were determined using multivariate Cox proportional hazards analysis. Results: Fhit and Wwox were ubiquitously expressed in benign samples and significantly and coordinately reduced in pancreatic, gallbladder, and ampullary cancers. In pancreatic cancers, Fdxr expression was positively correlated with Fhit and Wwox expression. Neither Fhit nor Wwox expression correlated with expression of other tumor suppressors or with clinicopathologic characteristics measured. Conclusion: Loss of Fhit and Wwox expression does not predict tumor progression or patient survival, suggesting that loss of expression of genes at the exquisitely replication stress sensitive chromosome fragile regions is an early event in the pathogenesis of cancers of the gallbladder, pancreas, and ampulla.",
author = "Mark Bloomston and Jeffrey Kneile and Matthew Butterfield and Mary Dillhoff and Peter Muscarella and Ellison, {E. Christopher} and Melvin, {W. Scott} and Croce, {Carlo M.} and Flavia Pichiorri and Kay Huebner and Frankel, {Wendy L.}",
year = "2009",
month = "8",
doi = "10.1245/s10434-009-0507-4",
language = "English (US)",
volume = "16",
pages = "2331--2338",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Coordinate loss of fragile gene expression in pancreatobiliary cancers

T2 - Correlations among markers and clinical features

AU - Bloomston, Mark

AU - Kneile, Jeffrey

AU - Butterfield, Matthew

AU - Dillhoff, Mary

AU - Muscarella, Peter

AU - Ellison, E. Christopher

AU - Melvin, W. Scott

AU - Croce, Carlo M.

AU - Pichiorri, Flavia

AU - Huebner, Kay

AU - Frankel, Wendy L.

PY - 2009/8

Y1 - 2009/8

N2 - Background: Loss of expression of fragile gene products, Fhit and Wwox, occurs in many cancer types, with loss exhibited early in the neoplastic process in some. Wwox has been understudied in pancreatobiliary cancers, especially in relation to other involved tumor suppressors. We have assessed the status of the Fhit and Wwox proteins encoded by DNA damage susceptible chromosome fragile sites encompassed by FHIT and WWOX tumor suppressor genes. Methods: Pancreatic, gallbladder and ampullary cancers, normal pancreas, chronic pancreatitis, and benign gallbladder specimens were stained for expression of Fhit, Fhit effector protein Fdxr, Wwox, and other tumor suppressors by immunohistochemistry, and comparisons were made between benign and malignant tissue. Correlations of expression among proteins and clinicopathologic features were sought using Spearman's rank order. Survival curves were created using the Kaplan-Meier method and compared by log-rank analysis. Predictors of survival were determined using multivariate Cox proportional hazards analysis. Results: Fhit and Wwox were ubiquitously expressed in benign samples and significantly and coordinately reduced in pancreatic, gallbladder, and ampullary cancers. In pancreatic cancers, Fdxr expression was positively correlated with Fhit and Wwox expression. Neither Fhit nor Wwox expression correlated with expression of other tumor suppressors or with clinicopathologic characteristics measured. Conclusion: Loss of Fhit and Wwox expression does not predict tumor progression or patient survival, suggesting that loss of expression of genes at the exquisitely replication stress sensitive chromosome fragile regions is an early event in the pathogenesis of cancers of the gallbladder, pancreas, and ampulla.

AB - Background: Loss of expression of fragile gene products, Fhit and Wwox, occurs in many cancer types, with loss exhibited early in the neoplastic process in some. Wwox has been understudied in pancreatobiliary cancers, especially in relation to other involved tumor suppressors. We have assessed the status of the Fhit and Wwox proteins encoded by DNA damage susceptible chromosome fragile sites encompassed by FHIT and WWOX tumor suppressor genes. Methods: Pancreatic, gallbladder and ampullary cancers, normal pancreas, chronic pancreatitis, and benign gallbladder specimens were stained for expression of Fhit, Fhit effector protein Fdxr, Wwox, and other tumor suppressors by immunohistochemistry, and comparisons were made between benign and malignant tissue. Correlations of expression among proteins and clinicopathologic features were sought using Spearman's rank order. Survival curves were created using the Kaplan-Meier method and compared by log-rank analysis. Predictors of survival were determined using multivariate Cox proportional hazards analysis. Results: Fhit and Wwox were ubiquitously expressed in benign samples and significantly and coordinately reduced in pancreatic, gallbladder, and ampullary cancers. In pancreatic cancers, Fdxr expression was positively correlated with Fhit and Wwox expression. Neither Fhit nor Wwox expression correlated with expression of other tumor suppressors or with clinicopathologic characteristics measured. Conclusion: Loss of Fhit and Wwox expression does not predict tumor progression or patient survival, suggesting that loss of expression of genes at the exquisitely replication stress sensitive chromosome fragile regions is an early event in the pathogenesis of cancers of the gallbladder, pancreas, and ampulla.

UR - http://www.scopus.com/inward/record.url?scp=67650996249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650996249&partnerID=8YFLogxK

U2 - 10.1245/s10434-009-0507-4

DO - 10.1245/s10434-009-0507-4

M3 - Article

C2 - 19434452

AN - SCOPUS:67650996249

VL - 16

SP - 2331

EP - 2338

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 8

ER -